Thus, we conclude that 1) elevated serum PCSK9 concentration could be a early biomarker for T2DM independent of other metabolic parameters; and 2) serum PCSK9 levels and 2-hPG are positively correlated in patients with metabolic diseases. Here, PCSK9 is linked to type 2 diabetes mellitus.